March 22 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:) :
* Bausch + Lomb - Bausch + Lomb Canada launches bepreve (bepotastine besilate ophthalmic solution) 1.5 pct w/v for allergic conjunctivitis Source text for Eikon: ID:nCNW68bG2a Further company coverage: VRX.TO